Grey Wolf Animal Health Corp. (TSXV:WOLF)

Canada flag Canada · Delayed Price · Currency is CAD
1.440
+0.040 (2.86%)
At close: Mar 3, 2026
34.58%
Market Cap 47.87M
Revenue (ttm) 33.47M
Net Income (ttm) 826.35K
Shares Out 34.19M
EPS (ttm) 0.02
PE Ratio 60.12
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,200
Average Volume 28,505
Open 1.420
Previous Close 1.400
Day's Range 1.420 - 1.440
52-Week Range 0.800 - 1.510
Beta 0.51
RSI 53.20
Earnings Date Apr 10, 2026

About Grey Wolf Animal Health

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under t... [Read more]

CEO Angela Cechetto
Employees 40
Stock Exchange TSX Venture Exchange
Ticker Symbol WOLF
Full Company Profile

Financial Performance

In 2024, Grey Wolf Animal Health's revenue was 26.83 million, an increase of 5.58% compared to the previous year's 25.41 million. Earnings were 704,668, an increase of 15.60%.

Financial Statements

News

There is no news available yet.